Cellectis (CLLS) Invested Capital (2014 - 2026)

Cellectis' Invested Capital history runs 13 years deep, the most recent figure standing at $68.8 million for Q1 2026.

• In Q1 2026, Invested Capital fell 48.25% year-over-year to $68.8 million; the TTM figure through Mar 2026 stood at $68.8 million (down 48.25% YoY), while the FY2025 annual figure was $190.0 million, down 29.49% from the prior year.
• Invested Capital was $68.8 million for Q1 2026 at Cellectis, down from $190.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $269.4 million in Q4 2024 to a low of $68.8 million in Q1 2026.
• Historically, Invested Capital has averaged $146.9 million across 5 years, with a median of $133.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 57.79% in 2023, then soared 162.25% in 2024.
• A 5-year view of Invested Capital shows it stood at $243.4 million in 2022, then sank by 57.79% to $102.7 million in 2023, then jumped by 162.25% to $269.4 million in 2024, then decreased by 29.49% to $190.0 million in 2025, then tumbled by 63.78% to $68.8 million in 2026.
• The last three Invested Capital figures came in at $68.8 million (Q1 2026), $190.0 million (Q4 2025), and $118.7 million (Q3 2025), per Business Quant data.